{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:56:39Z","timestamp":1790312199376,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.bbrc.2006.01.057","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T10:33:28Z","timestamp":1138358008000},"page":"1088-1095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Down-regulation of \u03b1-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson\u2019s disease rat model"],"prefix":"10.1016","volume":"341","author":[{"given":"Hiromi","family":"Hayashita-Kinoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikuni","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2006.01.057_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2006.01.057_bib2","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/hmg\/ddg283","article-title":"Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies","volume":"12","author":"Iwata","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2006.01.057_bib3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1471-4159.2001.00149.x","article-title":"Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult","volume":"76","author":"Lee","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2006.01.057_bib4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0028-3908(84)90170-9","article-title":"Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice","volume":"23","author":"Heikkila","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbrc.2006.01.057_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/311467a0","article-title":"Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors","volume":"311","author":"Heikkila","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2006.01.057_bib6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00001756-200404290-00021","article-title":"Oxidative stress and microglial activation in substantia nigra following striatal MPP+","volume":"15","author":"Miwa","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbrc.2006.01.057_bib7","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2006.01.057_bib8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","article-title":"Animal models of Parkinson\u2019s disease: an empirical comparison with the phenomenology of the disease in man","volume":"103","author":"Gerlach","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbrc.2006.01.057_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00001756-200001170-00041","article-title":"MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons","volume":"11","author":"Kowall","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbrc.2006.01.057_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1460-9568.2003.02408.x","article-title":"The mouse MPTP model: gene expression changes in dopaminergic neurons","volume":"17","author":"Kuhn","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbrc.2006.01.057_bib11","doi-asserted-by":"crossref","first-page":"15240","DOI":"10.1074\/jbc.M312497200","article-title":"Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide","volume":"279","author":"Kalivendi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2006.01.057_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(02)02422-8","article-title":"MPP+ increases alpha-synuclein expression and ERK\/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells","volume":"935","author":"Gomez-Santos","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2006.01.057_bib13","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.172514599","article-title":"Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP","volume":"99","author":"Dauer","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2006.01.057_bib14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0306-4522(03)00036-8","article-title":"Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice","volume":"118","author":"Schluter","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2006.01.057_bib15","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1096\/fj.02-0041fje","article-title":"Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3\/Akt kinase pathway","volume":"16","author":"Seo","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2006.01.057_bib16","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1523\/JNEUROSCI.23-12-05069.2003","article-title":"Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment","volume":"23","author":"Han","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2006.01.057_bib17","doi-asserted-by":"crossref","first-page":"10128","DOI":"10.1074\/jbc.M307563200","article-title":"Tyrosine-to-cysteine modification of human alpha-synuclein enhances protein aggregation and cellular toxicity","volume":"279","author":"Zhou","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2006.01.057_bib18","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1523\/JNEUROSCI.23-08-03095.2003","article-title":"Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration","volume":"23","author":"Manning-Bog","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2006.01.057_bib19","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1021\/bi00011a020","article-title":"Generality of the NUX rule: kinetic analysis of the results of systematic mutations in the trinucleotide at the cleavage site of hammerhead ribozymes","volume":"34","author":"Shimayama","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2006.01.057_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0378-1119(92)90035-N","article-title":"A method for generating transcripts with defined 5\u2032 and 3\u2032 termini by autolytic processing","volume":"122","author":"Altschuler","year":"1992","journal-title":"Gene"},{"key":"10.1016\/j.bbrc.2006.01.057_bib21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","article-title":"Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson\u2019s disease","volume":"91","author":"Yamada","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2006.01.057_bib22","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2006.01.057_bib23","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1523\/JNEUROSCI.3309-03.2004","article-title":"Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease","volume":"24","author":"Furuya","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2006.01.057_bib24","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.bbrc.2006.01.057_bib25","series-title":"Atlas of the Mouse Brain and Spinal Cord","author":"Sidman","year":"1971"},{"key":"10.1016\/j.bbrc.2006.01.057_bib26","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1073\/pnas.93.10.4565","article-title":"Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity","volume":"93","author":"Przedborski","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2006.01.057_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"4","author":"Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.bbrc.2006.01.057_bib28","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1073\/pnas.96.10.5774","article-title":"Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism","volume":"96","author":"Mandir","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2006.01.057_bib29","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1073\/pnas.191107398","article-title":"An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson\u2019s disease","volume":"98","author":"Mochizuki","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2006.01.057_bib30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP","volume":"74","author":"Vila","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2006.01.057_bib31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/hum.2005.16.262","article-title":"Parkin gene therapy for alpha-synucleinopathy: a rat model of Parkinson\u2019s disease","volume":"16","author":"Yamada","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbrc.2006.01.057_bib32","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2006.01.057_bib33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"Alpha-synuclein locus triplication causes Parkinson\u2019s disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"issue":"Suppl. 3","key":"10.1016\/j.bbrc.2006.01.057_bib34","first-page":"III11","article-title":"Aggregation of alpha-synuclein in the pathogenesis of Parkinson\u2019s disease","volume":"250","author":"Iwatsubo","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbrc.2006.01.057_bib35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","article-title":"Alpha-synuclein promotes mitochondrial deficit and oxidative stress","volume":"157","author":"Hsu","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2006.01.057_bib36","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1007\/PL00000671","article-title":"Alpha-synuclein and Parkinson\u2019s disease","volume":"57","author":"Lucking","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2006.01.057_bib37","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1038\/35017124","article-title":"Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson\u2019s disease?","volume":"2","author":"Goldberg","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2006.01.057_bib38","doi-asserted-by":"crossref","first-page":"48976","DOI":"10.1074\/jbc.M208192200","article-title":"Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2006.01.057_bib39","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.1090439","article-title":"Yeast cells provide insight into alpha-synuclein biology and pathobiology","volume":"302","author":"Outeiro","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2006.01.057_bib40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","article-title":"A Drosophila model of Parkinson\u2019s disease","volume":"404","author":"Feany","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2006.01.057_bib41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/1531-8249(200004)47:4<521::AID-ANA18>3.0.CO;2-B","article-title":"Synphilin-1 is present in Lewy bodies in Parkinson\u2019s disease","volume":"47","author":"Wakabayashi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2006.01.057_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/8820","article-title":"Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions","volume":"22","author":"Engelender","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2006.01.057_bib43","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1073\/pnas.0401081101","article-title":"Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson\u2019s disease","volume":"101","author":"Liani","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2006.01.057_bib44","doi-asserted-by":"crossref","first-page":"47870","DOI":"10.1074\/jbc.M203159200","article-title":"Parkin accumulation in aggresomes due to proteasome impairment","volume":"277","author":"Junn","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2006.01.057_bib45","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/01.WNL.0000139870.14385.3C","article-title":"Beta-synuclein gene alterations in dementia with Lewy bodies","volume":"63","author":"Ohtake","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2006.01.057_bib46","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm1001-1144","article-title":"Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease","volume":"7","author":"Chung","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2006.01.057_bib47","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2006.01.057_bib48","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrn1199","article-title":"The role of alpha-synuclein in Parkinson\u2019s disease: insights from animal models","volume":"4","author":"Maries","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2006.01.057_bib49","doi-asserted-by":"crossref","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP","author":"Schober","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbrc.2006.01.057_bib50","doi-asserted-by":"crossref","first-page":"52984","DOI":"10.1074\/jbc.M409028200","article-title":"Alpha-synuclein expression levels do not significantly affect proteasome function and expression in mice and stably transfected PC12 cell lines","volume":"279","author":"Martin-Clemente","year":"2004","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X06001057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X06001057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:17:39Z","timestamp":1758986259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X06001057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0006291X06001057"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2006.01.057","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Down-regulation of \u03b1-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson\u2019s disease rat model","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2006.01.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}